Trial of rPA-102 Vaccine in Healthy Adult Volunteers
Public ClinicalTrials.gov record NCT00100724. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Multi-Center, Randomized Dose-Finding Trial of rPA-102 Vaccine in Healthy Adult Volunteers
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety and immunogenicity of rPA102 vaccine given intramuscularly at 0 and 4 weeks over 2 dose ranges and 4 adjuvant levels.
Study identification
- NCT ID
- NCT00100724
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 480 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2004 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2005 (Type not available)
- Last update posted
- Jan 12, 2006
2004 – 2005
United States locations
- U.S. sites
- 12
- U.S. states
- 11
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA Ctr for Vaccine Research, LA Biomedical Research Institute | Torrance | California | 90502 | — |
| Emory Children's Clinic, Pediatric Infectious Disease | Atlanta | Georgia | 30322 | — |
| University of Kentucky, Markey Cancer Center | Lexington | Kentucky | 40536-0093 | — |
| Johns Hopkins University, Bloomberg School of Public Health | Baltimore | Maryland | 21205 | — |
| Mayo Clinic College of Medicine | Rochester | Minnesota | 55905 | — |
| St. Louis University, SoLUtions | St Louis | Missouri | 63104 | — |
| Infectious Disease Unit, University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229-3039 | — |
| Pediatric Clinical Trials Int'l, Inc. (PCTI) | Columbus | Ohio | 43205 | — |
| Primary Physicians Research, Inc. | Pittsburgh | Pennsylvania | 15241 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | — |
| University of Vermont College of Medicine, Vermont Vaccine Evaluation Center | Burlington | Vermont | 05405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00100724, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 12, 2006 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00100724 live on ClinicalTrials.gov.